Literature DB >> 8093971

Is p-ANCA in ulcerative colitis directed against beta-glucuronidase?

K Kaneko, Y Suzuki, Y Yamashiro, K Yabuta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8093971     DOI： 10.1016/0140-6736(93)92686-n

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

2.  Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.

Authors:  M Esteve; J Mallolas; J Klaassen; A Abad-Lacruz; F González-Huix; E Cabré; F Fernández-Bañares; X Bertrán; E Condom; J Martí-Ragué; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

3.  Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

Authors:  C Roozendaal; M H Zhao; G Horst; C M Lockwood; J H Kleibeuker; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.

Authors:  P Yang
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

Review 5.  ANCA in diseases other than systemic vasculitis.

Authors:  H H Peter; D Metzger; A Rump; E Röther
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

6.  Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass.

Authors:  D S Bansi; K A Fleming; R W Chapman
Journal:  Gut       Date:  1996-03       Impact factor: 23.059

7.  Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis.

Authors:  So Imakiire; Hidetoshi Takedatsu; Keiichi Mitsuyama; Hideto Sakisaka; Kozo Tsuruta; Masaru Morita; Nobuaki Kuno; Koichi Abe; Sadahiro Funakoshi; Hideki Ishibashi; Shinichiro Yoshioka; Takuji Torimura; Fumihito Hirai
Journal:  Gut Liver       Date:  2022-01-15       Impact factor: 4.519
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.